# communication-tool-repurposing

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/communication-tool-repurposing
- **Dataset:** https://optimly.ai/brand/communication-tool-repurposing.json
- **Markdown:** https://optimly.ai/brand/communication-tool-repurposing/llms.txt
- **Official website:** https://nature.com
- **Slug:** communication-tool-repurposing
- **Categories:** ai-machine-learning, data-analytics-business-intelligence, healthcare-it

## Overview

- **Tagline:** Uniquely addresses intercellular heterogeneity in drug repurposing by developing a drug score that considers all cell clusters from single-cell RNA sequencing data, leading to superior accuracy compared to both bulk-cell-based and other single-cell-based methods.
Source: Brand's website (https://nature.com) · 2026-10-04

- **Description:** ASGARD is a single-cell guided pipeline designed to aid in the repurposing of drugs. It defines a drug score to recommend drugs by considering intercellular heterogeneity within each patient by leveraging single-cell RNA sequencing (scRNA-seq) data. The tool aims to identify effective drugs for heterogeneous diseases, such as cancers and COVID-19, by analyzing drug efficacy across multiple cell clusters.
Source: Brand's website (https://nature.com) · 2026-10-04

## Offerings

- **Core capabilities:** ASGARD: A Single-cell Guided Pipeline to Aid Repurposing of Drugs (computational tool)
Source: Brand's website (https://nature.com) · 2026-10-04

- **Pricing:** Free for educational use (open-source on GitHub); commercial licensing information not provided, suggesting it's primarily an academic tool.
Source: Brand's website (https://nature.com) · 2026-10-04

## Audience

- **Target industry:** Researchers in drug discovery and development, computational biology, precision medicine, oncology, infectious diseases; academic institutions; pharmaceutical companies' R&D departments.
Source: Brand's website (https://nature.com) · 2026-10-04

## Landscape

- **Competitors:**
  - Alakwaa's pipeline
  - Guo et al.'s pipeline (using Seurat and CLUE)
  - Bulk-cell based drug repurposing methods
  - Other cell cluster-level predicting methods
Source: Brand's website (https://nature.com) · 2026-10-04

Page last updated 2026-10-17.